期刊文献+

晚期卵巢上皮性癌的治疗及预后分析 被引量:1

Treatment and Prognostic Factors of Advanced Epithelial Ovarian Cancer
下载PDF
导出
摘要 【目的】探讨晚期卵巢上皮性癌的治疗及预后影响因素。【方法】回顾性分析87例晚期卵巢上皮性癌的临床病理资料,应用COX风险比例模型判断影响预后的因素。【结果】多因素分析显示,临床分期、残余灶大小及术后化疗的疗程数是影响预后的重要因素。【结论】满意的肿瘤细胞减灭术及术后规则化疗可以改善晚期卵巢上皮性癌的预后。 [Objective]To study the treatment results and prognostic factors of advanced epithelial ovarian cancer. [Methods]The data of 87 patients presenting between Jan. 1993 and Dec. 1998 were analyzed retrospectively. Survival was calculated by Kaplan-Meier method and comparison was performed using Log-Rank test. Independent prognostic factors were identified by the COX proportional hazards regression model. [Results]Multivariate analysis showed that clinic stage, residual tumor and the number of course of chemotherapy were the most important prognostic factors. [Conclusion]Optimal surgical debulking and postoperative standard chemotherapy can improve survival of advanced cancer patients.
机构地区 湖南省肿瘤医院
出处 《医学临床研究》 CAS 2006年第6期848-850,共3页 Journal of Clinical Research
关键词 卵巢肿瘤/治疗 预后 ovarian neoplasms/TH prognosis
  • 相关文献

参考文献6

  • 1Eisenkop SM, Friedman RI., Wang HJ, et al . Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study[J]. Gynecol Oncol , 1998,69 : 103-108.
  • 2Delgado G, Oram DH, Mrco G, et al . Stage Ⅲ epithelial ovarian cancer: the role of maximal surgical reduction [J].Gynecol Oncol , 1984,18:293-297.
  • 3Hoskins EJ, Mcguire WP,Brade MF, et al . The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma[J]. Am J Obestet Gynecol , 1994,170:974-980.
  • 4吴鸣,沈铿,郎景和.Ⅳ期卵巢上皮性癌的治疗及预后影响因素[J].中华妇产科杂志,2000,35(4):200-204. 被引量:14
  • 5Chi DS. Liao JB, Leon LF, et aal . Identification of prognostic factors in advanced epithelial ovarian carcinoma[J]. Gynecol Oncol ,2001,82(3) :532-537.
  • 6Hengstler JG, Lange J,Kett A,et al . Contribution of c-erbB-2 and topoisomerase Ⅱ a to chemoresistance in ovarian cancer[J]. Cancer Research ,1999,59:3206-3214.

二级参考文献1

共引文献13

同被引文献3

  • 1吴鸣,沈铿,郎景和,黄荣丽,黄惠芳,潘凌亚.Ⅲ期卵巢上皮性癌临床和预后因素分析[J].中华医学杂志,2005,85(20):1406-1409. 被引量:16
  • 2Hoskins E J, Meguire WP, Brade MF,et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma[ J ]. Am J Obestet Gynecol, 1994,170:974 - 980.
  • 3Piccart M J, Bertelsen K, James K, et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results [ J ]. J Natl Cancer Inst ,2000,92 (9) : 699 - 708.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部